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Abstract. Twenty cases of suspected drug induced liver injury (16
cases of which satisfied the criteria for at least a query positive diag-
nosis as based on the Fourth Congress of "Drugs and the Liver" in
Japan) were studied by the whole blood culture technique of lympho-
cyte blast transformation. The positive rate with this technique was
10%, and no more than 15% even with the addition of one query posi-
tive. One reason for the low positive rate was that there was not only
an allergic mechanism at work in the study group but that liver injury
due to direct cytotoxicity of the drug was involved also. For a drug
such as chlorpromazine with strong cytotoxicity for lymphocytes, it
was difficult to demonstrate a relationship between allergic mecha-
nisms and the drug with this method.
The administration of new drugs and an increased consumption of medicines
have resulted, over the past few years, in a substantial increase in the incidence
of drug induced liver injury (1,2). This problem now, therefore, holds an im-
portant place in clinical medicine.
Drug induced liver injury can be broadly divided into two groups. One is
liver damage due to drug allergy; the other is toxic liver damage in the strict
sense. It is thought that the majority of cases are due to some form of allergy to
the pharmaceutical involved, but the actual genesis is often unclear in the case of
individual drugs.
It is essential to determine the causative drug in the diagnosis of drug
induced liver injury, and at present, this is mainly carried out by carefully
questioning the patient about previous exposure to drugs. This can be no more
than conjecture, however, and the most effective way of characterizing the caus-
ative drug is by re-exposing the patient to the drug in question. This procedure
may induce dangerous allergic reactions. Skin tests usually are only occasionally
positive in the diagnosis of drug induced liver injury (3, 4), so they can not be
considered useful diagnostically. As an in vitro diagnostic test, the lymphocyte
blast transformation test first used in the diagnosis of drug allergy by Holland
and Mauer (5) in 1964 has also been applied to the diagnosis of drug induced liver
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injury and has proven useful (6-9).
Recently, Mizoguchi et ai. (10) reported that it was possible to determine the
causative drug in drug allergic hepatitis by using a micro-blood culture version of
the lymphocyte blast transformation test. In comparison to the traditional tech-
nique of using separated lymphocytes, this technique requires only a small
amount of blood, so it is very easy to study the nature of the reaction of lympho-
cytes to various drug concentrations, and to determine the relevant optimal drug
concentrations.
The present work, therefore, was undertaken to examine the etiological
mechanism of drug induced liver injury as well as an assessment of the usefulness
of the whole-blood-culture lymphocyte blast transformation test in the diagnosis
of this problem.
MATERIALS AND METHODS
Study group. The study group comprised 20 cases of suspected drug induced
liver injury who presented to the First Department of Internal Medicine, Oka-
yama University Hospital or to its affiliated hospitals during the period from
August, 1975, to December, 1976 (Table 1). Lymphocyte blast transformation
tests were performed by the addition of either the causative drug, or purified
protein derivatives of tuberculin (PPD) in a further 2 cases of drug eruption
without liver injury and in one normal person with a positive tuberculin reac-
tion.
As is shown in Table 1, 15 (cases 1-15) of the 20 cases studied satisfied the
diagnostic criteria 1,2 or 1,3 of drug induced liver injury based on the Fourth
Congress of "Drugs and the Liver" (Table 2). The remaining 5 cases did not
fulfil the criteria but were strongly suspected of being drug induced liver injury
from their clinical course. The 28 types of suspected causative drugs in these
cases are listed in Table 1 and include 4 cases of ampicillin, 3 cases each of
sulphonamide and halothane, and 2 cases of sulpyrin. In 15 of these cases,
biopsy specimen obtained by peritoneoscopy was used for histological diagnosis.
The two cases of drug eruption had generalized erythema after the admin-
istration of cephazolin or sulpyrin. However, in these cases no liver injury was
demonstrated. Case 4, a suspected case of drug induced liver injury, developed
generalized erythema due to ampicillin administration after liver function tests
had returned to normal. A test of re-exposure to the same drug confirmed its
causative role in the drug eruption, so the lymphocyte blast transformation test
was performed using this drug.
Methods. The lymphocyte blast transformation test was performed using
whole blood culture as in the method of Mizoguchi et al. (10) (Table 3). De-
pending on the number of drugs to be tested, 2-5 ml of blood was taken from
the patient and mixed with 10 units of Heparin (Novo Co.) per ml of blood.
Aliquots of 0.1 ml were then aseptically placed in small test tubes and 0.01-0.1 ml
of test solution together with Eagle MEM added to make a total volume of l.Oml.
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Controls in which only Eagle MEM was added to the blood were also set up.
To each test tube, 200 units of penicillin G and 100,ug of streptomycin were
added as antibiotics but this step was omitted where these drugs were possible
causative agents.
When the drug to be tested was water soluble, it was added to each test tube
in a concentration approximately l/5ooo of the one-shot dose normally given to
TABLE l. DETAILS OF STUDY GROUP
Patient Ag S Suspected causative Latent Pruri- Jaun- Eosino- WBCperiod Fever Rash philsno. e ex drug (days) tus dice (%) (No./mm3)
63 M Dideoxy-KM-B 10
Halothane 10 + + 1100
Cephazolin 10
2 52 F Iopanoic acid 2 + + + + 3 2300Ampicillin 2
3 32 F Propylthiouracil 76 + + 2 3900
4 28 F Chloramphenicol 30
Cephaloridine 30 + + + + 7600
Sulfadimethoxine 30
Ampicillin'" 4
5 62 M Erythromycin estolate 31 + + 0.5 3125
6 49 F Ampicillin 9 + + 12 4500
7 31 F Ampicillin 120 + + 3 8200
8 43 F Halothane + + 12600
9 52 F Sulfisomezole 30 + + + 5500
10 27 F Triacetyloleandomycin 0 13000+ tetracycline
11 55 F Ajmaline 9 + + + 0 4900
12 26 F Ampicillin 7
Acetoaminophen 7 + + +
Salicylamide 7
13 62 M Streptomycin 59 16 7900Isoniazid 59
14 59 M Pyridinol carbamate 90 + + + 9300Trychlormethiazide 97
15 51 M Chlorpromazine 36 + +
16 M Sulfisomezole
Sulpyrin +Indomethacin
Aminopyrin
17 18 F Propranolol 2 2 3500Clofibrate 86
18 60 M Hexamethonium bromide 20
Oxytetracycline 14 7500
Sulpyrin 14
19 34 F Halothane 8 + 3 5200
20 23 F Paraaminosalicylic acid 14 1 4350
'" Proven cause of a drug eruption in this patient.
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TABLE 2. DIAGNOSTIC CRITERIA, HISTOPATHOLOGICAL CLASSIFICATION AND
IMMUNOLOGICAL DIAGNOSTIC CRITERIA FOR DRUG-INDUCED LIVER INJURY
Drug induced liver injury can be broadly divided into two groups. One is toxic liver in-
jury, and the other is liver injury due to drug allergy. It is thought that the majority of
cases are due to some form of allergy to the pharmaceutical involved. (These criteria are
applied for the liver injury due to allergy.)
I. Diagnostic criteria
1. Disturbed liver function one to four weeks* after drug ingestion
2. The appearance of fever, rash, pruritus, and jaundice of skin or mucous membranes
as initial symptoms (more than two of these to constitute a positive finding)
3. Eosinophilia (more than 6%) or leucocytosis
4. Liver injury provoked by accidental re-medication
5. A positive lymphocyte culture test
* the period is not strictly limited.
Definite diagnosis requires the presence of I and 4, or 1 and 5.
Suspected diagnosis must fulfill 1 and 2, or 1 and 3.
II. Histopathological classification
Hepatocellular type:
In this type, histological changes in the liver resemble those of acute viral hepatitis.
Namely, degeneration and necrosis of liver cell constitute the main findings, the
area of necrosis being focal, zonal or sometimes massive. Hepatic cells unaffected
by necrosis show remarkable variety in size and staining. Cell infiltration and
enlarged or proliferated Kupffer cells are present in sinusoids, and infiltration of
round cells, neutrophils and sometimes eosinophils together with proliferation of
bile ductule are seen in the portal area.
Cholestatic type:
In this type, cholestasis in the central area of the lobule is the most remarkable
finding. Bile plugs in the bile capillaries and bilirubin deposits in hepatic cells are
dominant. There is little hepatocellular necrosis and cell infiltration of sinusoids
is rare. Neither inflammatory reactions nor bile ductule proliferation is ever pre-
sent. A typical causative drug of this type is Cwalkylated anabolic steroid hormone.
Combined type:
This type has features of both cholestatic and hepatocellular types. Any of the
following may be seen: bile plugs in the central area of lobules, bilirubin deposits
in Iiver cells; degeneration and necrosis of liver cells; infiltration of round cells,
neutrophils, eosinophils; and bile ductule proliferation.
III. Immunological diagnostic criteria
Lymphocyte transformation test
1. Morphological observtion of blast cells-at least 5% of blast cells to be present
for a positive response.
2. Separated lymphocyte culture method
a. 3H-uridine uptake-at least 170% uptake needed to be positive
b. 3H-thymidine uptake-at least 200% uptake needed to be positive
3. Whole blood culture method
a. 3H-thymidine uptake-at least 170% uptake needed to be positive
4
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TABLE 3. PROFORMA FOR THE LYMPHOCYTE BLAST TRANSFORMATION
TEST BY WHOLE BLOOD CULTURE
0.1 ml heparinized blood
J,
Mix with 0.9ml Eagle MEM containing 200 unit penicillin and 100 pg streptomycin
J,
Add an antigen (causative drug etc.) or PHA
J, Incubate at 37°C with 5% C02 and 95% air for 24 hr
Add l~Ci of 3H-thymidine
J, Incubate at 37°C with 5% C02 and 95% air for 24 hr
Add 3 ml distilled water
J,
Filtrate through a glass filter (GF/C, Whatman)
J,
Wash the filter with 10 ml cold physiological saline
J,
Wash the filter with 5 ml cold physiological saline
J,
Wash the filter with 5ml cold 5% TCA
J,
Dry the filter
J,
Count by a liquid scintillation counter
191
an adult. This was based on the fact that, clinically, a normal dose is diluted
by the total blood volume in man (5000 ml).
For non-water soluble drugs, fetal calf serum was added to the drug. This
was shaken at room temperature for 10 min, centrifuged at 2000 r. p. m., and
0.01-0.1 ml of the supernatant used as the test drug solution. In these cases, a
proportionate amount of fetal calf serum was also added to the controls.
With halothane, the concentration was 71 mg/dl by the above method. It
was estimated that at the time of addition of drug solutions, the concentration
of halothane in the culture fluid ranged from 7.1 up to 7l,ug/ml. In case 2, io-
panoic acid (Telepaque), which is insoluble in water, was omitted and a similar
iodine compound, iodipamide (Biligrafin), used in its place. A further test con-
sisted of adding 0.01 ml of PHA (bacto-phytohemagglutinin-M, Difco Lab., 1 vial
dissolved in 5ml of Eagle MEM) in place of the test drug solution and repeating
the experiments using the same protocol.
Culture was performed in a sterile carbon dioxide incubator under an at-
mosphere of 5% carbon dioxide and 95% air for 48hr. The small test tubes were
inclined at a slope of approximately 15° to the horizontal. Twenty-four hr prior
to the completion of culture, lO,ul (l.0 ,uCi) of 3H-thymidine (specific activity
10.7 Cifmmole, radioactive concentration l.OCi/ml, Daiichi Chemicals) diluted
in 10 times its volume of Eagle MEM was added. After the termination of
culture, hemolysis was produced by adding 3 ml of distilled water and the fluid
was then immediately transferred to a glass filter (GF /C, diameter 2.4 em,
Whatman) and suction applied. The filter was washed first with 15 ml of cold
physiological saline, then with cold 5% trichloracetic acid, dried, 5 ml of "Sin-
tillator" (toluene 1 L, PPO 5.0 g, POPOP 0.1 g) added, and the uptake measured
by a liquid scintillation counter (LS-lOOC, Beckman). A stimulation index (S.L)
was then calculated by the following formula:
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S.l. = ~:pm of the drug added group
cpm of the control group
All of the above experiments were performed in duplicate and the average S.l.
value for each group calculated.
In one group of the patients, patch and intradermal tests were performed in
addition to the lymphocyte blast transformation tests. Routine data recorded
for all the subjects studied included clinical sym,ptoms, numbers of peripheral
eosinophils and leucocytes, serum GOT (SGOT), serum GPT (SGPT), serum
alkaline phosphatase (AlP), HBsAg, i-globulin (r-gl.), rheumatoid factor (RF),
antinuclear factor (ANF), liver histology, and medical and family histories.
RESULTS
Lymphocyte blast transformation tests using whole blood culture. Culture was
performed using identical blood from a normal person as non-treated and PHA-
treated groups. The results are shown in Table 4. The average value for the
non-treated group (mean ± standard deviation, SD) was 315.3 ± 27.9-1- cpm and
the SD/mean ratio was 8.9%. In the PHA-treated group, the mean was 18687.3
± 1113.7, an SD/mean ratio of 6.0%.
TABLE 4. 3H-THYMIDINE UPTAKE IN LYMPHOCYTES IN 0.1 ML
WHOLE BLOOD FROM A NORMAL PERSON
3H-thymidine uptake (cpm/O.l ml whole blood)
Tube no.
I
2
3
4
5
6
7
8
9
10
Non-treated group
263
276
335
340
332
291
319
321
321
355
PHA-treated group
17628
20735
19630
17686
18019
17394
19022
19384
The lymphocyte blast transformation test was performed by using blood
from a tuberculin positive person and adding 0.1 :g, 1.0! g, and 10.0 pg of PPD.
This method was also us~d to determine the most suitable culture time (Table 5).
The result was that the 1.0,' g PPD added test had a maximum S.l. of 1.80 at 48 hr
culture, while the 10.0 pg test had lower S.L in the same culture time. For the
same concentration, the longer the culture time, the larger the 5.1. became.
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TABLE 5. LYMPHOCYTE BLAST TRANSFORMATION TEST WITH PPD BASED ON CULTURE
OF WHOLE BLOOD FROM A TUBERCULIN POSITIVE NORMAL SUBJECT
193
Lymphocyte stimulation index
Culture time
PPD (pg/mlj
(hr) PHA
0.1 1.0 10.0
~---,-------_ .._-
48 1. 45 1. 80 1. 45 37.35
72 2. 16 3.28 2.60 71. 60
96 2.20 4. 19 5.66 87. 10
120 4. 11 7.89 103.30
The 20 patients in the study group were tested with 3 different concentra-
tions of each of the 4 types of drug listed in Table 1. In each case, the drug
showing the maximum S.L and the amount added to achieve that maximum are
shown in Table 6. A comparison of these dosages at a standard value of 1/5000
of the normal one-shot dose showed that water-soluble drugs having an added
dose larger than the standard were the mixture of triacetyloleandomycin and
tetracycline (Sigmamycin) at 3 times the dose and dideoxy-KM-B, ampicillin,
and chlorpromazine each at 2.5 times the dose. The other drugs all had amounts
equal to, or less than, the standard.
A positive lymphocyte blast transformation test (S.I.> 1. 70) was seen in 2
(patients 1 and 16) of the study group, a positive rate of 10%. Case 4 had a de-
layed type reaction with the intradermal test using ampicillin and was query-
positive by the skin window method, the technique of Yoshida and Take (11),
with the same drug. A lymphocyte blast transformation test was performed
using ampicillin which had definitely been the causative agent of systemic ery-
thema on a test re-exposure. The S.1. was 1.41. If an S.1. greater than 1.41 is
taken as query positive, one more case (case 2) can be added to the series, so that
the incidence of positives becomes 15 %. Cases 13, 14, 15 and 20 had stimulation
indices less than 1.OJ and Case 15 in particular had an extremely low S.L of 0.48.
Of the cases of drug eruption, case 21 had an S.L of 1.78 and a positive lympho-
cyte blast transformation test and one other case was negative. The PHA addi-
tion tests which were performed at the same time in each case had a mean of
43.51 ± 25.46 in contrast to the mean of 32.61 ± 13.41 for the normal population.
Case 8 who had a low S.L of 1.42 for the PHA added test was receiving pred-
nisolone at the time.
Five cases with negative lymphocyte blast transformation tests were tested
with both patch tests and intradermal tests. There were no cases with a classical
positive reaction, but Case 9 showed a flare-up at the patch site 23 days after the
skin test with sulfisomezole.
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TABLE 7. CLINICAL AND LABORATORY FINDINGS
Patient SCOT SCPT AlP HBsAg 'Y-gl. RA test ANF Histology of liver (Interval
a ) Past history Family history
no. (unit) (unit) (B. L. u) (g/dl) (days)
I 621 231 (-) 2.32 (±) (-) Hepatocellular type (288) (-) (-)
2 86 99 20.7 (-) I. 25 (+) Other type (34) RAc (-)
3 1580 1300 6.9 (-) 3.29 (*) (- ) Hepatocellular type (94) Hyperthyroidism (-)
4 92 55 3.5 c-) 2.96 (*) (-) Hepatocellular type (84) Drug eruption (- ) t""'<
5 126 250 5.1 (-) I. 31 (-) Combined type (41 ) (-) RAC a'"tl
19.5b
::r
6 215 265 (-) (-) Hepatocellular type (57) (- ) (-) 0n
'<
7 216 355 25.0 (-) I. 74 (-) (+) Other type (200) (- ) (-) 0
8 1970 1680 6.0 (-) toj;
9 97 94 5.2 (-) 1.44 (-) (-) Hepatocell ular type (40) Asthma (-) ~
10 133 107 28.3b (-) 0.80 Hepatocellular type (41) (-) (-) ...,.,
Il>
II 130 350 12. I (-) I. 30 (-) Other type (36) Drug eruption ::l
'"-,
12 230 520 4.6 (-) 0.45 Hepatocellular type (38) (-) (-) 0.,
13 116 103 (- ) Lung tbc. a~
14 640 720 12.4b (-) 1.60 (-) Hepatocellular type (60) (-) (-) o'
::l
15 71 III 9.5 (-) 0.87 Lung tbc. ...,
16 (-) n~
17 960 1230 3.0 (-) 1.10 Hyperlipoproteinemia (-)
18 365 435 7.8 (-) I. 64 (+) Other type (38) (- ) (-)
19 247 480 9.8 (-) I. 07 (±) Hepatocellular type (34) (-) (-)
20 400 250 (-) I. 56 Hepatocellular type (212) Renal tbc. (-)
a The interval between the onset of drug induced liver injury and biopsy
b AlP in these three patients were measured as K. A. u.
C Rheumatoid arthritis
......
c.o
<...n
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TABLE 8. SUMMARY OF CLINICAL AND LABOLATORY FINDINCS
Sex Male
Female
Age 0-19 year
20-39
40-S9
60-
Latent period 0-30 days
31-60
61-
Fever
Rash
Pruritus
Jaundice
Eosinophilia
Leucocytosis
SGOT, SGPT levels (;;;; SOOu.)
AlP level (;;;; 9.0 BLu. or 30 KAu.)
'Y-gl. level 0-0.80 g/dl
0.81-1.7S
1.76<
RA test (+)
( ±)
(- )
ANF (+)
Histology Hepatocellular type
of liver Cholestatic type
Combined type
Other type
Total casesa
No. positive\No. examined
cases cases
7/20 (3S%)
13/20 (6S%)
1/19 ( S%)
7/19 (37%)
7/19 (37%)
4/19 (21%)
11/17 (64%)
3/17 (18%)
3/17 (18%)
S/18 (28%)
7/18 (39%)
11/19 (S8%)
13/20 (6S%)
2/16 (13%)
2/17 (12%)
6/19 (32%)
S/16 (31%)
2/16 (12%)
11/16 (69%)
3/16 (19%)
4/12 (33%)
2/12 (17%)
6/12 (50%)
1/ S (20%)
lO/lS (67%)
O/lS
l/lS ( 7%)
4/1S (27%)
Cases of definite or
suspected diagnosisb
No. positive\No. examined
cases cases
6/16 (37%)
10/16 (63%)
O/IS
S/lS (33%)
7/1S (47%)
3/1S (20%)
8/14 (S8%)
3/14 (21%)
3/14 (21%)
4/14 (29%)
7/14 (50%)
II/IS (73%)
13/16 (81%)
2/12 (17%)
2/13 (1S%)
S/lS (33%)
4/13 (31%)
2/12 (17%)
7/12 (S8%)
3/12 (2S%)
3/10 (30%)
1/10 (10%)
6/10 (60%)
1/ S (20%)
8/12 (67%)
0/12
1/12 ( 8%)
3/12 (2S%)
Cases of definite
diagnosis C
--~_._---------~--
No. positive/No. examined
cases cases
2/3
1/3
0/2
0/2
1/2
1/2
2/2
0/2
0/2
1/2
1/2
2/2
2/2
0/2
0/2
1/2
1/2
0/2
1/2
1/2
1/2
1/2
0/2
0/1
1/2
0/2
0/2
1/2
......
(,0
0)
~
..,
>~
>
"i
>
a. 20 cases composed of 16 cases of definite or suspected diagnosis of drug induced liver injury and 4 cases which did not fulfil
the diagnostic criteria but were strongly suspected of being drug induced liver injury from their clinical course
b. 16 cases composed of 3 cases of definite diagnosis and 13 cases of suspected diagnosis
c. 3 cases of definite diagnosis with positive lymphocyte blast transformation test
10
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Clinical symptoms and laboratory results of the study group. The clinical symp-
toms and laboratory findings of the study group are shown in Tables 1 and 7.
The 20 cases comprising the total study group and the 16 cases who fulfilled the
diagnostic criteria in Table 2 for more than a suspected diagnosis are summarized
in Table 8. As the total number of cases of definite diagnosis with positive lym-
phocyte transformation tests (including 1 query positive) was small, only the
number of cases is recorded.
There was a sex preponderance of females (1 0 cases, 63 %) in the 16· Cases
(Cases 1-16) who fulfilled the diagnostic criteria of at least a suspected diagnosis.
The latent period for 8 of 14 cases was less than 30 days (58 %) and, for the
majority of cases, less than 60 days (11 of 14 cases, 79%). The most frequent
clinical symptom in the drug induced liver injury was jaundice (13 of 16 cases,
81 %), followed by pruritus (11 of 15 cases, 73 %), rashes (7 of 14 cases, 50 %) and
fever (4 of 14 cases, 29 %). Eosinophilia occurred in 2 of 12 cases (1 7%) and
leucocytosis in 2 of 13 cases (15 %). SGOT and SGPT levels greater than 500
units occurred in 5 of 15 cases (33 %). AlP levels exceeded 30 KA units or 9.0 BL
units in 4 of 13 cases (31 %). All cases were HBs antigen negative. Normal {'-
globulin levels (taken as 0.81-1.75 g/dl (12)) occurred in 7 of 12 cases (58%) and
the combined number of those exceeding normal values (3 of 12 cases, 25 %) and
those less than the normal values (2 of 12 cases, 17%), that is, those with ab-
normal values, totalled 42 %.
RF measured by the RA test (Hyland Co.) was positive in 30f 10 cases
(30 %), and if those showing (±) reactions were also included, totalled 4 of 10
cases (40%). ANF was positive in 1 of 5 cases examined: Liver histology of
biopsy specimens obtained by peritoneoscopy 34 to 288 days after the onset of the
syndrome was classified according to the criteria in Table 2. The hepatocellular
type was most frequent (8 of 12 cases, 67%), there were no cases of the pure
cholestatic type, and there was 1 case (of 12 cases) of the combined type. Further
3 cases which did not comply with this classification were grouped together.
These included one case of non-specific reactive hepatitis, one case of plasma cell
infiltration in the interstitial tissue, and one case of proliferated bile ductules but
in which there was little change in the hepatic cells. A futher one case only (Case
6) showed eosinophil infiltration of the hepatic tissue.
A past history of chronic rheumatoid arthritis, asthma, or drug eruption
was presented in 4 of 14 cases (29%). There were no particular family histories.
The above clinical findings did not indicate any large differences among the
total group of 20 patients. The finding, however, that the RA test was always at
least (±) in the cases which had positive or query-positive lymphocyte blast
transformationt tests was characteristic.
11
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DISCUSSION
It is now known that the phenomenon discussed by Nowell (13) in 1964 of
lymphocyte blast transformation during culture with PHA added to the medium
also occurs during the culture of peripheral lymphocytes with specific antigens
added (14, 15). In drug allergy, it is generally not possible for the administered
drug, by itself, to become an antigen but it is considered that, working as a
hapten and binding with the individual's proteins, that is, carrier proteins, the
drug acquires antigenicity and induces an allergic reaction (16, 17). In the study
of patients with drug allergies, Holland and Mauer (5) were first to use in vitro
addition of the suspected drug as a hapten, perform lymphocyte culture, and, by
observing the lymphocyte blast transformation phenomenon which occurred,
characterise the causative drug. Various workers are continuing this research
(18-21).
In drug induced liver injury it is generally thought that the drug combines
with protein originating in the liver, acquires antigenicity, and via the individ-
ual's immunological response induces an allergic response in the liver. There are
as yet, however, few reports analysing causative drugs to drug induced liver
injury by this method and the positive incidences reported are different from each
other (6, 22-25). In Japan, there have been publications by Tsuji et at. (7),
Namihisa et at. (8), Kato (9), Mizoguchi (26), and Yamada (27), and of these,
Yamada detected a high rate of positive lymphocyte blast transformation tests
(57 of 83 cases) by using a whole blood culture technique.
The present research was an analysis of drug allergy in terms of doses in-
volved and incidence rates in patients who were suspected of drug induced liver
injury on clinical examination and liver biopsy, especially patients in whom
allergic mechanisms, as defined by criteria bas~d on the Fourth Congress of
"Drugs and the Liver", were thought to be involved. The result of whole blood
culture was a positive rate of 10% (2 of 20 cases), and even if one query positive
case is included, the rate was still only 15%. The author's experimental method
had no problems in term of culture conditions and technique. This was indicated
by the following; the standard deviations of cpm of 3H-thymidine uptake in the
non-treated and PHA-treated groups for the normal person were small, there
was a good response to the addition of PPD in tuberculin positive case, a positive
result was obtained in the one case of drug eruption thought to be a classical
drug allergy, and there was an adequate respons: of the S.l. in all cases (excluding
case 8 undergoing prednisolone treatment) to the addition of PHA.
Furthermore, there was no great difference between the present experiments
and those of other workers in either concentration of drugs used or intervals be-
tween the onset of the syndrome and the time of this test. The reason for the low
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incidence of positives in spite of selecting patients who were strongly indicated
clinically as having allergy type drug induced liver injury can be considered as
being due to the inclusion of cases in whom a positive result for the lymphocyte
blast transformation test was difficult to obtain. Dove et at. (23) suggested that
the absence of positive lymphocyte blast transformation tests in patient with iso-
niazid-associated hepatitis was possibly related to isoniazid toxicity and this idea
is also applicable to the present author's results as well. Especially in the case of
chlorpromazine in patient 15, the addition dose was low in comparison with
other drugs and certainly was not excessive in terms of usual doses of chlorpro-
mazine, so the demonstration of an extremely low S.l. must be considered as
evidence of strong cytotoxicity for lymphocytes. This cytotoxicity can also affect
all cells of the body, including hepatic cells, and it is a point of great interest that
the cytotoxicity of chlorpromazine, which is a representative drug causing aller-
gic drug induced liver injury, may be associated with the mechanism of drug
induced liver injury. Moreover, this technique was considered unsuitable for the
investigation of allergic mechanisms in the case of drugs having such marked
cytotoxicity for lymphocytes. At present, the macrophage migration inhibition
test is also used in diagnosis of allergy type of drug induced liver injury, and in
this method the cytotoxicity of drugs is a problem because of the inhibition due
to the cytotoxicity of added drugs.
On the other hand, concerning the cytotoxicity itself, it may be thought that
this whole blood culture method has possibilities as a method to study drug cyto-
toxicity in vitro for its peculiarity of being able to examine various drug concen-
trations.
In addition to the problem of cytotoxicity, further problems which influence
the positive rate of this experiment remain to be clarified in the future. These
problems include the standard for the positive response in this method, the most
suitable length of culture time, and the problem of carrier proteins.
Skin tests are a simple technique for the diagnosis of causative drugs in drug
induced liver injury, but the positive rate is generally low. Goto et ai. (28), how-
ever, performed patch and intradermal tests in cases of drug induced liver injury
in which rashes were also present and diagnosed positive delayed type reactions
in all 7 cases. In the author's 5 cases of negative lymphocyte blast transforma-
tion tests, all skin test results were regarded as negative, but in one of the cases
which had a concomitant rash, a flare-up was seen in the patch area on the 23rd
day after exposure to the drug suspected as being the causative drug of the liver
injury. The mechanism of this phenomenon is unclear but it is an interesting
finding, and in combination with the results of Goto et ai. (28), it seems partially
useful to perform skin tests in drug induced liver injury, especially with rashes.
There are no reports of using the skin window method to diagnose the causative
13
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drug in drug induced liver injury, but skin window assessment of the status of
eosinophils and basophils, a technique which differs from conventional diagnostic
methods, needs further study.
In the 16 cases of the study group which fulfilled the diagnostic criteria,
females were in the majority and the latent period was less than two months in
the majority. This agrees with various other authors' findings. Clinical symp-
toms are also included in the diagnostic criteria and as a whole had a high in-
cidence in the group, but fever had a lower rate than other workers' report. This
was probably due to the fact that it is more difficult to be certain subjectively
about fever than it is for the other symptoms. The incidence of both eosinophilia
and leucocytosis in peripheral blood was low and may have been due to the fact
that in the most of the cases blood analyses were not performed immediately after
the onset of symptoms. Cases with SCOT and SCPT levels greater than 500
units or cases with AlP levels greater than 30 KA units or 9.0 BL units were seen
at the same frequency; that is, approximately 1/3 of the total cases. The former
was considered to indicate the hepatocellular type clinically, while the latter the
cholestatic type. Those cases showing abnomallevels of r-gl. and those showing
positive RA test (including (±) reactions) were approximately 40%, and these
abnormalities often continued after the other liver function tests returned to
normal. This was considered as indicating one aspect of abnormal immunol-
ogical responsiveness of the individual with drug induced liver injury. The posi-
tive ANF case and the family histories of allergy may also reflect this abnormal
immunological responsiveness.
Liver histology was represented mainly by the hepatocellular type, there
being no cases of the cholestatic type. The four cases grouped as cholestatic type
on the grounds of laboratory values were classified histologically as hepatocellular
type or types other than the above two. This may have been due to the fact that
the liver biopsies were taken more than 34 days after the onset of symptoms
when improvement in the various laboratory values had been recognized. It is
thought that recovery from cholestatic type of liver injury is relatively prompt
and without residual abnormalities. The low incidence of eosinophil infiltration
in hepatic tissue was also thought to be due to the time of biopsy.
From all this, it was concluded that, when classifying drug induced liver
injury using laboratory data and hepatic histology, it is important to consider the
stage at which they were performed in order to accurately interpret the informa-
tion.
This work was presented at the 4th Japanese Congress of Clinical Immu-
nology, Okayama, 1976.
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